SCHEMBL2176860

SCHEMBL2176860

COCCNc1nccc(-c2cc(N(C(=O)O)C(C)(C)C)c3cc(OC)ccc3c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.38
NCOR1 O75376 1/20 0.38
HDAC2 Q92769 1/20 0.38
MKNK1 Q9BUB5 3/20 0.38
CLK4 Q9HAZ1 5/20 0.37
DYRK1A Q13627 4/20 0.37
DYRK1B Q9Y463 3/20 0.37
CLK1 P49759 3/20 0.37
CLK2 P49760 3/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
KDR P35968 2/20 0.35
AURKA O14965 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178733 0.91 MKNK1 (0.48) HDAC3NCOR1HDAC2MKNK1CLK4
SCHEMBL2178583 0.90 CCNT1 (0.45) HDAC3NCOR1HDAC2MKNK1CLK4
SCHEMBL2179774 0.89 CLK4 (0.50) HDAC3NCOR1HDAC2MKNK1CLK4
SCHEMBL2179735 0.87 ACP1 (0.44) HDAC3NCOR1HDAC2MKNK1CLK4
SCHEMBL2178948 0.86 DYRK1A (0.48) HDAC3NCOR1HDAC2MKNK1CLK4
SCHEMBL2177853 0.86 CCNT1 (0.46) CLK4DYRK1AKDM4EALDH1A1LMNA
SCHEMBL2178358 0.86 CASR (0.42) MKNK1CLK4LMNAAURKAGSK3B
SCHEMBL2177434 0.86 VNN1 (0.42) HDAC3NCOR1HDAC2MKNK1CLK4
SCHEMBL2179118 0.86 PRKD3 (0.39) HDAC3NCOR1HDAC2MKNK1CLK4
SCHEMBL2180425 0.86 HDAC3 (0.44) HDAC3NCOR1HDAC2MKNK1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP HDAC3 1641/4885NCOR1 418/4885HDAC2 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.